SOD2 and cancer: Mechanistically, hsa-miR-324-mediated inhibition of the SOD2-activated oncogenicity and the cancer stem cell-like phenotype of CRC cells is a probable critical component of our observed 4-AAQB—FOLFOX anticancer synergism.